CGON insider plans sale of 20,237 common shares

CGON reporting person James Mulay filed to potentially sell common stock through Morgan Stanley Smith Barney, indicating up to 20,237 shares with an aggregate value of $1,483,776.84 as of 07/10/2026.

Accepted by SEC EDGAR 07/10/2026 - 04:41 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

CGON reporting person James Mulay filed to potentially sell common stock through Morgan Stanley Smith Barney, indicating up to 20,237 shares with an aggregate value of $1,483,776.84 as of 07/10/2026. The shares relate to an exercise of stock options for cash and are listed on NASDAQ.

Key Figures

Planned shares for potential sale: 20,237 shares Aggregate value of planned sale: $1,483,776.84 Recent 10b5-1 sale on 06/15/2026: 1,964 shares for $118,075.68 +2 more

5 metrics

Planned shares for potential sale 20,237 shares Common stock associated with exercise of stock options as of 07/10/2026

Aggregate value of planned sale $1,483,776.84 Common stock to be sold as reported in securities information

Recent 10b5-1 sale on 06/15/2026 1,964 shares for $118,075.68 Common stock sold under 10b5-1 plan

Recent 10b5-1 sale on 04/17/2026 15,600 shares for $1,139,024.64 Common stock sold under 10b5-1 plan

Exchange listing NASDAQ Exchange for the common stock referenced in the filing

Key Terms

Form 144, Exercise of Stock Options, 10b5-1 Sales

3 terms

Form 144 regulatory

"144: Securities Information Common | Morgan Stanley Smith Barney LLC"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Stock Options financial

"Common | 07/10/2026 | Exercise of Stock Options | Issuer"

10b5-1 Sales regulatory

"10b5-1 Sales for JAMES MULAY 3000 Pegasus Park Drive"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CGON Form 144 filing by James Mulay disclose?

The filing discloses that James Mulay may sell CGON common stock, with up to 20,237 shares valued at $1,483,776.84 as of 07/10/2026 through a broker.

How many CGON shares are planned for potential sale in this Form 144?

The Form 144 indicates a potential sale of 20,237 shares of CGON common stock, associated with an exercise of stock options for cash and listed on NASDAQ.

What prior CGON stock sales has James Mulay reported in the last 3 months?

The filing lists two prior sales: 1,964 shares for $118,075.68 on 06/15/2026 and 15,600 shares for $1,139,024.64 on 04/17/2026 under 10b5-1 sales.

What is the transaction type related to the CGON shares in this Form 144?

The CGON shares covered by this Form 144 are tied to an Exercise of Stock Options for cash, with the issuer as the counterparty and a date of 07/10/2026.

Which broker is handling the potential CGON stock sale for James Mulay?

The potential CGON stock sale is associated with Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

On which exchange is the CGON common stock in this Form 144 listed?

The common stock referenced in the Form 144 for CGON is listed on NASDAQ, as indicated in the securities information section of the disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001684531
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CG Oncology, Inc.
SEC File Number	001-41925
Address of Issuer	3000 Pegasus Park Drive, Suite 1640 Dallas TEXAS 75247
Phone	9494093700
Name of Person for Whose Account the Securities are To Be Sold	JAMES MULAY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20237	1483776.84	88202473	07/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/10/2026	Exercise of Stock Options	Issuer			20237	07/10/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES MULAY 3000 Pegasus Park Drive, Suite 1640 Dallas TX 75247	Common	06/15/2026	1964	118075.68
10b5-1 Sales for JAMES MULAY 3000 Pegasus Park Drive, Suite 1640 Dallas TX 75247	Common	04/17/2026	15600	1139024.64

144: Remarks and Signature

Remarks
Date of Notice	07/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Mulay
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)